Artificial Intelligence (AI) has become the new norm in business these days. Where humans lack the ability to analyze and detect the smallest detail in mounds of data, AI usually makes up for it. That’s exactly what Devlyn Grupo thought as the company signed an agreement with a small Canadian-based company to assist in the early detection of critical health issues pertaining to vision.
Diagnos Inc. (TSX-V:ADK) made headlines today after Devlyn Grupo, an optical retailer with over 900 stores in Mexico and Guatemala, signed a contract with them to use their AI for their optics business. With such a large number of storefronts to assist in the early detection of vision-threatening diseases, Diagnos Inc. has positioned itself well for potential growth. In addition to the already-staggering number of stores, the press release said that Devlyn could be rolling out more stores as early as 2021.
This was welcomed news by traders as the stock traded up to $0.435/share (+11.5%) in early trade. This move comes after a very bullish September as it broke out of the range it was in for roughly a year.